SBIR-STTR Award

Targeted VEGF Methylation: Novel Cancer Therapy
Award last edited on: 1/16/04

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$475,604
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Carl O Pabo

Company Information

Sangamo Therapautics Inc (AKA: Sangamo BioSciences Inc)

501 Canal Boulevard Suite A100
Richmond, CA 94804
   (510) 970-6000
   busdev@sangamo.com
   www.sangamo.com
Location: Multiple
Congr. District: 11
County: Contra Costa

Phase I

Contract Number: 9R44CA094795-02
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2002
Phase I Amount
$311,997
This abstract is not available

Phase II

Contract Number: 5R44CA094795-03
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2003
Phase II Amount
$163,607
This abstract is not available